The Protein A Resin Market is estimated to be valued at US$ 474.0 Mn in 2022 and is expected to exhibit a CAGR of 8.5% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.
Protein A resin is widely used in the biopharmaceutical industry for purification of monoclonal antibodies. It offers high binding capacity and selectivity, making it an essential material in protein purification processes. The increasing demand for monoclonal antibodies for therapeutics, diagnostics, and research purposes is driving the growth of the protein A resin market. Additionally, advancements in chromatography techniques and the introduction of novel protein A resins are further contributing to market growth. The global protein A resin market is expected to witness significant growth due to its precise purification capabilities and the expanding biopharmaceutical industry.
The protein A resin market is driven by two main factors. Firstly, the increasing demand from the biopharmaceutical industry for monoclonal antibody purification is fuelling market growth. Monoclonal antibodies are extensively used in the treatment of various diseases, such as cancer, autoimmune disorders, and infectious diseases. This has led to a rise in the production of monoclonal antibodies by biopharmaceutical companies, thereby driving the demand for protein A resin for their purification.
Secondly, the rising adoption of monoclonal antibodies in therapeutics and diagnostics is propelling market growth. Monoclonal antibodies offer targeted therapy with minimal side effects, leading to their increasing adoption in the treatment of various diseases. Moreover, the growing application of monoclonal antibodies in diagnostics for accurate detection and monitoring of diseases is driving the demand for protein A resin.
The protein A resin market can be segmented based on material type, application, and end-user. In terms of material type, agarose-based protein A resins dominate the market. Agarose-based resins have a high binding capacity, excellent selectivity, and are widely used in the pharmaceutical and biotechnology industries. These resins are preferred over other types due to their stability and compatibility with various purification techniques. They are extensively used in antibody purification processes, making them the dominating sub-segment in the protein A resin market.
Political: The political landscape plays a crucial role in shaping the protein A resin market. Government policies regarding the biotechnology and pharmaceutical industries, intellectual property protection, and regulations on the use of protein A resins in different countries influence the market’s growth.
Economic: Economic factors such as GDP growth, disposable income, and healthcare expenditure impact the demand for protein A resins. Increasing healthcare spending by emerging economies and the growing biopharmaceutical industry contribute to market growth.
Social: Rising awareness about personalized medicine, increasing healthcare expenditure, and the growing aging population create a favorable environment for the protein A resin market. The demand for drugs and therapies derived from monoclonal antibodies is increasing, driving the need for protein A resins.
Technological: Technological advancements in protein purification processes and the development of more efficient protein A resins contribute to market growth. Improvements in resin capacity, robustness, and productivity enhance the overall efficiency of downstream processes.
The global Protein A Resin Market is expected to witness high growth, exhibiting a CAGR of 8.5% over the forecast period (2020-2027). This growth can be attributed to the increasing demand for monoclonal antibodies in the biopharmaceutical industry. Monoclonal antibodies are extensively used in the treatment of various diseases such as cancer, autoimmune disorders, and infectious diseases. This drives the demand for protein A resins for antibody purification processes.
In terms of regional analysis, North America is the fastest-growing and dominating region in the protein A resin market. The presence of major biopharmaceutical companies, technological advancements, and government support for research and development activities contribute to the region’s growth. Additionally, the increasing prevalence of chronic diseases and the growing demand for advanced therapies propel the market in North America.
Key players operating in the protein A resin market include GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd. These key players are focused on product innovation, strategic collaborations, and mergers and acquisitions to strengthen their market presence and expand their product portfolios.